Repros Therapeutics

Repros names new top exec
Bizjournals.com
Tue, 04/11/17 - 10:10 am
Repros Therapeutics
Pharma CEOs
Larry Dillaha
The FDA is keeping its partial hold on Repros’ Proellex
Endpoints
Mon, 04/10/17 - 10:14 pm
FDA
Proellex
Repros Therapeutics
6 Biotechs Seriously on the Move
24/7 Wall St
Fri, 06/3/16 - 10:47 am
biotech
Eleven Biotherapeutics
Achaogen
Repros Therapeutics
OncoGenex
Cellectar
Keryx
Repros Therapeutics posts loss of $6.3 million in fourth quarter
Yahoo/AP
Mon, 03/14/16 - 10:03 am
Repros Therapeutics
earnings
FDA to Repros: Wipe your PhIII drawing board clean and start over
Fierce Biotech
Wed, 12/2/15 - 09:34 am
FDA
Repros Therapeutics
enclomiphene
Androxal
low testosterone
4 Key FDA Decisions Expected in November and December
24/7 Wall St
Sun, 11/1/15 - 11:18 am
FDA
Androxal
Repros Therapeutics
elvitegravir
cobicistat
emtricitabine
tenofovir alafenamide
OPuS-2
Biocryst
Synergy Pharmaceuticals
plecanatide
Repros tanks on another FDA hurdle for its 'low-T' treatment
Fierce Biotech
Fri, 10/30/15 - 09:51 am
Repros Therapeutics
testosterone
FDA
Androxal
8 BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Sat, 10/24/15 - 02:28 pm
AbbVie
Gilead Sciences
Endo International
Synta Pharmaceuticals
Valeant Pharmaceuticals
Relypsa
Repros Therapeutics
Ocular Therapeutix
Repros shares rally on testicle-stimulation drug application
Marketwatch
Thu, 04/2/15 - 09:58 am
Repros Therapeutics
testosterone
enclomiphene citrate
Androxal
Repros Therapeutics reports 4Q loss
Yahoo/AP
Mon, 03/16/15 - 10:55 am
earnings
Repros Therapeutics
Repros plummets as the FDA deals a blow to its low-T hopes
Fierce Biotech
Fri, 10/17/14 - 09:27 am
Repros Therapeutics
testosterone
FDA
Androxal
Repros says its testosterone drug found superior in study
Yahoo/Reuters
Thu, 08/28/14 - 08:52 am
testosterone
Repros Therapeutics
Androxal
4 Key Positive Biotech Stock Catalysts Coming Very Soon
24/7 Wall St
Thu, 07/17/14 - 04:15 pm
Amicus Therapeutics
Baxter International
Halozyme
Intercept Pharmaceuticals
Repros Therapeutics
Narrower-than-Expected Q4 Loss at Repros
Yahoo/Zacks.com
Fri, 03/14/14 - 11:13 am
Repros Therapeutics
earnings
Repros Shares Soar After FDA Meeting
Yahoo/Zacks.com
Fri, 02/7/14 - 10:37 am
FDA
Repros Therapeutics
Androxal
Repros Therapeutics: Small Biotech Play Analysts Believe Can Double
Seeking Alpha
Sat, 11/30/13 - 09:18 am
Repros Therapeutics
Insiders Are Buying Repros Therapeutics
Seeking Alpha
Sat, 11/16/13 - 01:16 pm
Repros Therapeutics
Androxal Makes Repros A Buy
Seeking Alpha
Sat, 11/2/13 - 11:25 am
Androxal
Repros Therapeutics
hypogonadism
This Week in Biotech
Motley Fool
Sun, 10/27/13 - 12:48 pm
Immunomedics
Zogenix
Gilead Sciences
Osiris Therapeutics
Repros Therapeutics
Repros plummets as FDA questions testosterone drug data
Fierce Biotech
Thu, 10/24/13 - 10:26 am
FDA
Repros Therapeutics
testosterone
Androxal

Pages